In addition, TIGIT blockade was previously shown to prevent NK cell exhaustion and promote NK-dependent anti-tumoural responses in murine models [74], whilst we showed that TIGIT blockade could augment the NK cytotoxicity of oncolytic adenovirus-infected human ovarian cancer cells [67]. The gene discussed is TIGIT; the disease is ovarian cancer.